BIO-TECHNE Corp Logo

BIO-TECHNE Corp

Develops reagents and instruments for life sciences research and clinical diagnostic markets.

TECH | US

Overview

Corporate Details

ISIN(s):
US09073M1045
LEI:
Country:
United States of America
Address:
614 MCKINLEY PL N E, 55413 MINNEAPOLIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bio-Techne Corporation is a global life sciences company that develops, manufactures, and supplies high-quality reagents, instruments, and services for the research and clinical diagnostic markets. The company empowers scientists and clinicians by providing innovative workflow solutions designed to accelerate discovery and improve patient health. Its portfolio includes a wide range of research tools, such as recombinant antibodies and assays, as well as automated instruments for protein analysis, identity, and purity assessment. Bio-Techne focuses on providing reproducible and consistent results, with key applications in areas like next-generation cell and gene therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIO-TECHNE Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIO-TECHNE Corp

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIO-TECHNE Corp via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tvardi Therapeutics, Inc. Logo
Developing oral STAT3 inhibitors to treat cancers and fibrosis-driven diseases.
United States of America
TVRD
Tyra Biosciences, Inc. Logo
Biotech developing precision FGFR medicines for cancer and genetic disorders.
United States of America
TYRA
UCB Logo
UCB
Biopharma firm developing treatments for severe neurological and immunological diseases.
Belgium
UCB
Ultragenyx Pharmaceutical Inc. Logo
Develops and commercializes novel therapies for rare and ultra-rare genetic diseases.
United States of America
RARE
Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.
Hong Kong
690
Unicycive Therapeutics, Inc. Logo
A clinical-stage biotech developing novel treatments for kidney diseases, led by oxylanthanum carbonate.
United States of America
UNCY
UNION KOREA PHARM CO.,Ltd Logo
Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.
South Korea
080720
uniQure N.V. Logo
Developing AAV-based gene therapies for rare liver and central nervous system disorders.
United States of America
QURE
UNITED THERAPEUTICS Corp Logo
Develops therapies for chronic diseases and manufactures organs for transplantation.
United States of America
UTHR
Universe Pharmaceuticals INC Logo
Manufactures, markets, and distributes TCM derivative products and biomedical drugs.
United States of America
UPC

Talk to a Data Expert

Have a question? We'll get back to you promptly.